CR20130657A - Ensayo de lisiloxidasa-homólogo 2 y métodos de uso del mismo - Google Patents

Ensayo de lisiloxidasa-homólogo 2 y métodos de uso del mismo

Info

Publication number
CR20130657A
CR20130657A CR20130657A CR20130657A CR20130657A CR 20130657 A CR20130657 A CR 20130657A CR 20130657 A CR20130657 A CR 20130657A CR 20130657 A CR20130657 A CR 20130657A CR 20130657 A CR20130657 A CR 20130657A
Authority
CR
Costa Rica
Prior art keywords
test
lisyloxidase
homologist
methods
same
Prior art date
Application number
CR20130657A
Other languages
English (en)
Spanish (es)
Inventor
Victoria Smith
Joanne I Adamkewicz
Susan K Lyman
Jason Chien
Xiaoming Li
Lixin Shao
Jeffrey D Bornstein
Original Assignee
Gilead Biologics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46208194&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR20130657(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gilead Biologics Inc filed Critical Gilead Biologics Inc
Publication of CR20130657A publication Critical patent/CR20130657A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Silicon Polymers (AREA)
CR20130657A 2011-06-01 2013-12-13 Ensayo de lisiloxidasa-homólogo 2 y métodos de uso del mismo CR20130657A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161492210P 2011-06-01 2011-06-01
US201161550895P 2011-10-24 2011-10-24
US201161578813P 2011-12-21 2011-12-21

Publications (1)

Publication Number Publication Date
CR20130657A true CR20130657A (es) 2014-05-16

Family

ID=46208194

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20130657A CR20130657A (es) 2011-06-01 2013-12-13 Ensayo de lisiloxidasa-homólogo 2 y métodos de uso del mismo

Country Status (25)

Country Link
US (3) US20140206017A1 (enExample)
EP (1) EP2714744A1 (enExample)
JP (3) JP2014523521A (enExample)
KR (1) KR20140048156A (enExample)
CN (1) CN103946241A (enExample)
AP (1) AP2013007285A0 (enExample)
AR (1) AR086657A1 (enExample)
AU (2) AU2012261883A1 (enExample)
BR (1) BR112013030682A2 (enExample)
CA (1) CA2837534A1 (enExample)
CL (1) CL2013003445A1 (enExample)
CO (1) CO6940375A2 (enExample)
CR (1) CR20130657A (enExample)
EA (1) EA201391627A1 (enExample)
EC (1) ECSP13013092A (enExample)
IL (1) IL229631A0 (enExample)
MA (1) MA35212B1 (enExample)
MD (1) MD20130098A2 (enExample)
MX (1) MX2013013905A (enExample)
PE (1) PE20141450A1 (enExample)
PH (1) PH12013502490A1 (enExample)
TW (1) TW201319572A (enExample)
UY (1) UY34115A (enExample)
WO (1) WO2012167181A1 (enExample)
ZA (1) ZA201308812B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030114410A1 (en) 2000-08-08 2003-06-19 Technion Research And Development Foundation Ltd. Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
CA2693310C (en) * 2007-08-02 2018-11-27 Arresto Biosciences, Inc. Lox and loxl2 inhibitors, antibodies and uses thereof
US9107935B2 (en) 2009-01-06 2015-08-18 Gilead Biologics, Inc. Chemotherapeutic methods and compositions
CA2771702A1 (en) 2009-08-21 2011-02-24 Gilead Biologics, Inc. Catalytic domains from lysyl oxidase and loxl2
BR112012019693A2 (pt) 2010-02-04 2017-06-20 Gilead Biologics Inc anticorpos que se ligam à lisil oxidase-like 2 (loxl2) e métodos de uso para eles.
WO2014070939A1 (en) * 2012-10-30 2014-05-08 Gilead Sciences, Inc. Therapeutic and diagnostic methods related to lysyl oxidase-like 2 (loxl2)
WO2015187499A1 (en) 2014-06-03 2015-12-10 Gilead Sciences, Inc. Use of an ask1 inhibitor for the treatment of liver disease, optionally in combination with a loxl2 inhibitor
EA201692202A1 (ru) 2014-06-11 2017-06-30 Джилид Сайэнс, Инк. Способы лечения сердечно-сосудистых заболеваний
MA41252A (fr) 2014-12-23 2017-10-31 Gilead Sciences Inc Formes solides d'un inhibiteur d'ask 1
JP2019510752A (ja) 2016-03-04 2019-04-18 ギリアード サイエンシーズ， インコーポレイテッド オートタキシン阻害剤の組成物及び合剤
JP2019513737A (ja) 2016-04-08 2019-05-30 ギリアード サイエンシーズ， インコーポレイテッド がん、炎症性疾患および自己免疫疾患を処置するための組成物および方法
GB201704206D0 (en) 2017-03-16 2017-05-03 Nordic Bioscience As Lysyl oxidase like-2 assay
US20230152330A1 (en) * 2021-11-17 2023-05-18 AmMax Bio, Inc. Detection and treatment of idiopathic pulmonary fibrosis

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6352862B1 (en) * 1989-02-17 2002-03-05 Unilever Patent Holdings B.V. Analytical test device for imuno assays and methods of using same
FI92882C (fi) * 1992-12-29 1995-01-10 Medix Biochemica Ab Oy Kertakäyttöinen testiliuska ja menetelmä sen valmistamiseksi
US20030114410A1 (en) * 2000-08-08 2003-06-19 Technion Research And Development Foundation Ltd. Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
CA2693310C (en) 2007-08-02 2018-11-27 Arresto Biosciences, Inc. Lox and loxl2 inhibitors, antibodies and uses thereof
JP2010038735A (ja) * 2008-08-05 2010-02-18 Terumo Corp 腹膜機能の評価方法および腹膜機能評価用イムノクロマト試験紙
RU2012110580A (ru) * 2009-08-21 2013-09-27 Джилид Байолоджикс, Инк. Способы скрининга in vivo
BR112012019693A2 (pt) * 2010-02-04 2017-06-20 Gilead Biologics Inc anticorpos que se ligam à lisil oxidase-like 2 (loxl2) e métodos de uso para eles.
US9556882B2 (en) * 2011-05-10 2017-01-31 Borgwarner Inc. Turbocharger with variable turbine geometry

Also Published As

Publication number Publication date
MX2013013905A (es) 2014-05-14
US20170269085A1 (en) 2017-09-21
AR086657A1 (es) 2014-01-15
KR20140048156A (ko) 2014-04-23
JP2016164578A (ja) 2016-09-08
IL229631A0 (en) 2014-01-30
AU2016244254A1 (en) 2016-11-03
MD20130098A2 (ro) 2014-06-30
AU2016244254B2 (en) 2018-10-18
JP2014523521A (ja) 2014-09-11
NZ618682A (en) 2016-04-29
BR112013030682A2 (pt) 2016-12-06
UY34115A (es) 2013-01-03
WO2012167181A1 (en) 2012-12-06
CL2013003445A1 (es) 2014-07-25
AU2012261883A1 (en) 2013-05-02
AP2013007285A0 (en) 2013-11-30
ZA201308812B (en) 2014-08-27
JP2018049033A (ja) 2018-03-29
EA201391627A1 (ru) 2014-08-29
US20120309020A1 (en) 2012-12-06
CO6940375A2 (es) 2014-05-09
PH12013502490A1 (en) 2014-01-20
MA35212B1 (fr) 2014-06-02
EP2714744A1 (en) 2014-04-09
CN103946241A (zh) 2014-07-23
TW201319572A (zh) 2013-05-16
US20140206017A1 (en) 2014-07-24
CA2837534A1 (en) 2012-12-06
PE20141450A1 (es) 2014-11-06
ECSP13013092A (es) 2014-08-29

Similar Documents

Publication Publication Date Title
ECSP13013092A (es) Ensayo de lisiloxidasa-homólogo 2 y métodos de uso del mismo
MX360236B (es) Uso de marcadores en el diagnostico y tratamiento de cancer de prostata.
CO2019012771A2 (es) Ensayos de diagnóstico para detectar, cuantificar y/o rastrear microbios y otros analitos
UY34764A (es) Derivados de 2,2-difluoropropionamida de metilo de bardoxolona, formas polimórficas y sus métodos de uso
AR077237A1 (es) Polimeros colorantes
CL2014003110A1 (es) Anticuerpo anti-fcrn; secuencias que lo codifican; vector; célula huésped; proceso de producción; composición farmacéutica que lo comprende; uso para el tratamiento de enfermedad autoinmune; y ensayo para probar la capacidad de un anticuerpo para bloquear la actividad de fcrn humano.
AR082388A1 (es) Metodo para identificar un compuesto que tiene un efecto antiarritmico asi como los usos relacionados con el mismo
MX2014011797A (es) Ensayos basados en interrogatorios celulares y uso de los mismos.
UY34484A (es) Benzotienilo-pirrolotriazinas disustituidas y sus usos
EA201600085A1 (ru) Набор для обнаружения соевого события syht0h2
MX2013004172A (es) Metodos y kits para la deteccion de células tumorales circulantes en pacientes pancreáticos por medio del uso de captura poliespecífica y reactivos de detección de cocteles.
MX2017008817A (es) Composiciones y metodos para la glicosilacion de proteinas.
EA201590630A1 (ru) Способы лечения и диагностики, связанные с лизилоксидазоподобным белком 2 (loxl2)
CR20150247A (es) Anticuerpos de antihemaglutinina y métodos de uso
UY34200A (es) 3-(fluorovinil)pirazoles y su uso
EA201500080A1 (ru) Способ in vitro диагностирования и мониторинга рака
CO2017005773A2 (es) Composiciones, dispositivos, y métodos de pruebas de sensibilidad del ibs
UY34160A (es) Ligandos del receptor trpm8 y su uso en diversos tratamientos
MX2016001719A (es) Metodos y equipos para predecir el riesgo de tener una enfermedad o evento cardiovascular.
MX2015007213A (es) Formulaciones de la solución de los anticuerpos anti-il-23p19 manipulados genéticamente.
MX380642B (es) Ceramidas y su uso en el diagnostico de enfermedad cardiovascular (ecv).
UY34590A (es) Fenilimidazopirazoles sustituidos y su uso
MX2015010740A (es) Tratamiento del cancer basado en el estratificacion de anhidrasa carbonica ix (caix).
MX374601B (es) Procedimientos y series para su uso en los mismos.
BR112016002709A2 (pt) queratinas como biomarcadores para câncer cervical e sobrevivência